Stefan Pöhlmann Selected Research

Chronic Kidney Failure (Chronic Renal Failure)

12/2021

Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Pöhlmann Research Topics

Disease

73	Infections 04/2024 - 04/2002
47	COVID-19 04/2024 - 01/2020
19	Virus Diseases (Viral Diseases) 03/2024 - 11/2004
12	Vesicular Stomatitis 03/2024 - 06/2004
7	Human Influenza (Influenza) 01/2022 - 07/2009
5	Severe Acute Respiratory Syndrome 01/2022 - 06/2004
5	Ebola Hemorrhagic Fever 04/2021 - 08/2002
4	Coronavirus Infections 01/2023 - 09/2014
3	Lung Injury 01/2022 - 01/2010
3	Inflammation (Inflammations) 01/2022 - 01/2021
3	Filoviridae Infections 01/2019 - 11/2004
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 01/2006
2	Breakthrough Infections 11/2022 - 11/2022
2	Hemorrhage 01/2022 - 11/2021
2	Critical Illness (Critically Ill) 12/2021 - 01/2021
2	Neoplasms (Cancer) 01/2019 - 07/2009
2	Fever (Fevers) 04/2013 - 11/2011
1	Convalescence 04/2024
1	Fatigue 02/2024
1	RNA Virus Infections 10/2022
1	Fibrosarcoma 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Hypoxia (Hypoxemia) 12/2021
1	Lymphopenia (Lymphocytopenia) 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021

Drug/Important Bio-Agent (IBA)

28	Antiviral Agents (Antivirals)IBA 01/2023 - 11/2011
26	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2004
17	AntibodiesIBA 04/2024 - 06/2004
17	Peptide Hydrolases (Proteases)FDA Link 03/2021 - 01/2006
15	VaccinesIBA 11/2022 - 05/2005
15	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2020 - 08/2002
14	Glycoproteins (Glycoprotein)IBA 01/2024 - 09/2002
9	Neutralizing AntibodiesIBA 11/2022 - 06/2004
8	Serine Proteases (Serine Protease)IBA 01/2023 - 07/2009
7	InterferonsIBA 01/2023 - 01/2017
7	LectinsIBA 10/2020 - 08/2002
6	camostatIBA 01/2022 - 04/2015
6	Bone Marrow Stromal Antigen 2IBA 01/2019 - 11/2011
5	BNT162 VaccineIBA 11/2022 - 01/2021
5	SARS-CoV-2 spike proteinIBA 01/2022 - 11/2020
4	Messenger RNA (mRNA)IBA 04/2024 - 01/2021
4	Monoclonal AntibodiesIBA 03/2024 - 10/2021
4	bamlanivimabIBA 01/2022 - 01/2021
4	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021 - 11/2020
4	Polysaccharides (Glycans)IBA 10/2020 - 01/2008
4	C-Type Lectins (C-Type Lectin)IBA 07/2011 - 01/2003
3	Angiotensin-Converting Enzyme 2IBA 01/2023 - 07/2004
3	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 10/2022
3	AcidsIBA 01/2021 - 11/2020
3	CeramidesIBA 01/2021 - 11/2020
3	EnzymesIBA 11/2020 - 12/2011
3	Sialic AcidsIBA 01/2018 - 10/2010
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 10/2022
2	dalbavancinIBA 09/2022 - 01/2021
2	CytokinesIBA 01/2022 - 10/2011
2	AntioxidantsIBA 01/2022 - 11/2021
2	Amino Acids FDA Link 01/2022 - 09/2006
2	Cysteamine (Mercaptamine)FDA Link 01/2022 - 11/2021
2	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 11/2021
2	sphingosine kinaseIBA 12/2021 - 04/2021
2	Ac-GQFR-kbtIBA 10/2021 - 05/2021
2	3,5-diisopropylsalicylic acid (DIPS)IBA 10/2021 - 01/2021
2	nafamostatIBA 10/2021 - 01/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2021 - 08/2020
2	Amitriptyline (Elavil)FDA LinkGeneric 01/2021 - 11/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 11/2020
2	LigandsIBA 01/2021 - 01/2017
2	AntigensIBA 11/2020 - 03/2020
2	CarbohydratesIBA 10/2020 - 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 04/2024
1	EpitopesIBA 06/2023
1	Fondaparinux (Arixtra)FDA Link 01/2023
1	AntithrombinsIBA 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	AnticoagulantsIBA 01/2023
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2023
1	COVID-19 VaccinesIBA 11/2022
1	molnupiravirIBA 10/2022
1	cilgavimabIBA 10/2022
1	sotrovimabIBA 10/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	2- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acidIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	PeptidomimeticsIBA 01/2022
1	pol Gene ProductsIBA 01/2022
1	imdevimabIBA 01/2022
1	AerosolsIBA 01/2022
1	LipidsIBA 12/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2021
1	HDL LipoproteinsIBA 12/2021
1	LyasesIBA 12/2021
1	Serum AlbuminIBA 12/2021
1	2019-nCoV Vaccine mRNA-1273IBA 12/2021
1	otamixabanIBA 10/2021

Therapy/Procedure

15	Therapeutics 01/2023 - 08/2002